dog-on-beach-cell-frisbee
30 September 2013Americas

Teaching old drugs new tricks

For a variety of reasons, some drugs disappear into pharmaceutical obscurity. Problems with IP licensing, toxicity, or lack of understanding about the mechanism of a drug at the time of its discovery may all be to blame, though some of these abandoned medicines can be picked up by new companies and repurposed or repositioned for use within the context of modern care where unmet needs remain.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
12 March 2026   The event unpacked how technology, litigation trends, and global events are adding complexity while also offering benefits for legal teams under pressure to reduce costs.
Americas
12 March 2026   The pharma company has successfully enforced its patents against Ascent’s proposed mirabegron copy, shortly after inking licensing deals elsewhere over the medication.
Americas
9 March 2026   Appeals court upholds lower court’s ruling, clarifying key legal questions concerning patent claims for blood‑testing devices.